AIMIT Tech Reviewabout 1 hour ago
AI drug discovery raises patent credit questions
4 min read
Insilico Medicine's AI proposed a pulmonary fibrosis drug, which the company credited to its generative platform. AI now generates drug designs as easily as ChatGPT writes notes, but patent protection for such inventions raises unresolved credit questions.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
